How many drugs treat Partial seizure?

Drug Landscape tracks 7 marketed treatments for Partial seizure (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/partial-seizure.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Partial seizure — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Partial seizure (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Partial seizure, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Xcopri	CENOBAMATE	Sk Life		Gamma-aminobutyric acid receptor subunit alpha-4	2019-01-01
Briviact	BRIVARACETAM	UCB		Synaptic vesicle glycoprotein 2A	2016-01-01
Aptiom	ESLICARBAZEPINE ACETATE	Sumitomo Pharma Am	eslicarbazepine acetate	Sodium channel alpha subunit	2013-01-01
Fycompa	PERAMPANEL	Catalyst Pharms	Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]	Glutamate receptor ionotropic AMPA	2012-01-01
Xcopri	Xcopri	SK Life Science, Inc.		Gamma-aminobutyric acid receptor subunit alpha-4, Gamma-aminobutyric acid receptor subunit alpha-6
Fycompa	Fycompa	Eisai Inc.		Glutamate receptor ionotropic AMPA
Zebinix	Zebinix	Centre Hospitalier Saint Joseph Saint Luc de Lyon		Sodium channel alpha subunit

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Catalyst Pharms · 1 drug in Partial seizure
Centre Hospitalier Saint Joseph Saint Luc de Lyon · 1 drug in Partial seizure
Eisai Inc. · 1 drug in Partial seizure
SK Life Science, Inc. · 1 drug in Partial seizure
Sk Life · 1 drug in Partial seizure
Sumitomo Pharma Am · 1 drug in Partial seizure
UCB · 1 drug in Partial seizure

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Partial seizure:

Cite this brief

Drug Landscape (2026). Partial seizure — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/partial-seizure. Accessed 2026-06-10.

Partial seizure full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing